Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Oxford medicines optimisation presentation


Published on

A brief presentation on medicines optimisation and the input a clinical pharmacist can make in improving treatment outcomes for patients and help make evidence led cost effective improvements for the wider NHS.

Published in: Health & Medicine
  • I have recently read your book and must congratulate you on the most informative and revolutionary contents. Your book has drastically changed my life and the way I view health. I am so grateful for your discovery of this information and for sharing it with the world. ➤➤
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Oxford medicines optimisation presentation

  1. 1. Medicines Optimisation Richard Harris MRPharmS 21/11/2016 1
  2. 2. Medicines Optimisation Aim Identification, Intervention and Resolution of adverse medicines performance, inappropriate prescribing and compliance issues  Improve Treatment Outcomes for Patients  Improve value for money for the wider NHS  Improve quality, safety & optimal treatment outcomes based on best evidence  Patient Engagement 21/11/2016 2
  3. 3. Clinical Screen (Identify) Best Practice (Plan) Medicine Optimisation (Action) Review Outcomes (Evaluate) Patient 3
  4. 4. 21/11/2016 4 How Can Pharmacists Contribute ?  Ensure safe prescribing & administration of medication that adheres to best evidence & practice  Cost effective-QIPP drop lists -drugs of limited clinical value  Assess Drug History & Monitor for Polypharmacy/ prescribing cascades & ADEs-Document-Communicate-Challenge  Optimise Drug Therapy- Switching/ patent expiry  Medicines waste campaigns e.g. patient education awareness  Medicines Optimisation Training (MDT/GP Practices/ Care Homes)  Provide co-ordinated medicine information to patients/carers/relatives as part of the discharge-planning process
  5. 5. 21/11/2016 5 Case study - Elsie 78 • Recently discharged from hospital after a fall • She lives alone • Elsie says her mobility and eye sight are getting worse. • Takes Furosemide 40mg BD –doesn’t like ‘water tablet’ • Recently prescribed Nitrazepam to help poor sleep. • Reports feeling thirsty What Are The Risk Factors? • Age • Falls history • Adherence concerns-cognitive/physical • New medication • Undiagnosed disease? • Isolation Supporting Medicines Optimisation & reduce further falls • Is diuretic suitable? Consider recommending an alternative • Switch to a shorter acting benzodiazepine e.g. Zopiclone - consider cessation • Increased thirst may suggests undiagnosed diabetes-referral • Is Elsie managing to take her tablets OK on her own?- Ask the patient-check her medicines with her-advise on correct use - consider compliance aid • Wider question over independence : Engage with MDT/arrange care package
  6. 6. 21/11/2016 6 Case Study : Omega 3 Low Priority Poor Value The NHS Midlands and East spent £2.5 million on omega-3 fatty acids compounds in 2012-2013 Source: PrescQIPP Bulletin 47 October 2013 NICE Guideline-Evidence base PrescQIPP Drop List Letter of Advice/PIL to Patient Agree protocol/process Audit practice/patients Monitor savings - summary report Omacor I capsule daily = 28 day saving of £14.28 Medicine Stopped Pharmacist CCG Medicines Review Optimisation
  7. 7. 21/11/2016 7 •Prioritise: • Engage the patient in the process •Aim: • Keep regimes as simple as possible-reduce pill burden •Modify: • Make recommendations including cessation- “is the drug still needed?” •Prevent : • Adherence issues-check patient understanding, Identify & resolve barriers, explain & monitor changes Presentation Summary
  8. 8. Any Questions? 8 Thank You